Literature summary for 3.4.24.B7 extracted from

Savinov, A.Y.; Remacle, A.G.; Golubkov, V.S.; Krajewska, M.; Kennedy, S.; Duffy, M.J.; Rozanov, D.V.; Krajewski, S.; Strongin, A.Y.
Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients (2006), Cancer Res., 66, 2716-2724.

Search for more literature for 3.4.24.B7

Application

Application	Comment	Organism
medicine	MMP-26 is a valuable cancer marker, that contributers favorably to the survival of the estrogen receptor alpha/beta-positive cohort of breast cancer patients	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
breast carcinoma cell	-	Homo sapiens	-
mammary ductal carcinoma cell	in the course of further disease progression through stages I to III, the expression of MMP-26 decreases. The expression of MMP-26 in ductal carcinomas correlates with a longer patient survival	Homo sapiens	-
additional information	MMP-26 is not expressed in mammary epithelium	Homo sapiens	-

Synonyms

Synonyms	Comment	Organism
MMP-26	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)